DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dvn5gf/biotechnology) has announced the addition of the "Biotechnology Market in India" report to their offering.
The Indian biotechnology industry has been growing substantially in the last couple of years. Biotech companies have grown in the country exponentially as a liberalized intellectual property regime and skilled workforce along with low manufacturing costs have boosted the growth of the industry.
With the industry not facing much of the brunt from the global economic recession, the Indian biotechnology industry has been gathering investment and is benefitting from the cost cutting efforts ongoing in many developed countries.
With the diverse flora and fauna that India has, along with the large gene pool and ideal climate, the biotechnology market in India is progressing well, supported by favorable regulations by the Government of India.
Taiyou Research analyzes the potential of the Indian Biotechnology Industry in its research report Biotechnology market in India.
The report covers the following:
- A complete coverage of the global biotechnology market including industry definition, market profile, market statistics, industry performance, market segmentation, competition in the industry, global financing for biotechnology, and a future perspective.
- Moving to the analysis of the biotechnology market in India, we analyze the industry through a market profile, impact of the economic recession on the market, investment in the industry, and biotech companies in India.
- Major tie-ups in the recent years are looked at, along with the issue of Bt Brinjal that rocked the industry recently. The growth of stem cell research and biosimilars is analyzed.
- We carry out a segmented analysis of the industry through the following segments: biopharmaceuticals, bioservices, bioagri, bioindustrial, and bioinformatics.
- Emerging business models in the biotechnology industry in India are analyzed, along with industry strategies such as public-private partnerships.
- A Michael Porter's Five Forces analysis is carried out on the Indian biotechnology industry, wherein we analyze the buyers' power in the market, suppliers' power, rivalry among competitors, threat of new entrants in the market, and the threat of substitutes.
- Generic drugs have a big role to play in the Indian biotech market and we analyze that through a section on the role of biogenerics in India as well as the impact of generic drugs on the Indian biotech industry.
Key Topics Covered:
1. Executive Summary
2. Profile of the Global Biotechnology Industry
3. Biotechnology Market in India
4. Segment Analysis
5. Regulatory Reforms Accelerating Growth of Biotech
6. Emerging Business Models
7. Industry Strategies
8. India Biotechnology Market: Porter's Five Forces Analysis
9. Generic Drugs and the Indian Biotech Industry
10. Emergence of Biogenerics in India
11. Emergence of Biotech Parks
12. Major Players
13. Future of the Indian Biotechnology Market
14. Appendix
15. Glossary
Companies Mentioned
- Aurobindo Pharma Limited
- Bharat Biotech
- Biocon Limited
- Dr. Reddy's Laboratories
- GlaxoSmithKline Pharmaceuticals Limited
- Indian Immunologicals Ltd
- Jubilant Life Sciences Limited
- Morepen Laboratories
- Novo Nordisk
- Panacea Biotec
- Piramal Healthcare
- Quintiles Transnational Corporation
- Ranbaxy Laboratories (acquired by Daiichi Sankyo)
- Rasi Seeds
- Reliance Life Sciences
- Serum Institute of India
- Shantha Biotechnics (Part of Sanofi-Aventis Group)
- Stempeutics Research
- Wockhardt
For more information visit http://www.researchandmarkets.com/research/dvn5gf/biotechnology